MIT Gene Research May Explain Autistic Savants
Main Category: AutismAlso Included In: Neurology / Neuroscience
Article Date: 12 Feb 2008 - 17:00 PDT
| Patient / Public: | ![]() |
4.64 (11 votes) |
| Healthcare Prof: | ![]() |
|
| Article Opinions: | 1 posts |
Mice lacking a certain brain protein learn some tasks better but also forget faster, according to new research from MIT that may explain the phenomenon of autistic savants in humans. The work could also result in future treatments for autism and other brain development disorders.
Researchers at the Picower Institute for Learning and Memory at MIT report in the Feb. 13 issue of the Journal of Neuroscience that mice genetically engineered to lack a key protein used for building synapses-the junctions through which brain cells communicate-actually learned a spatial memory task faster and better than normal mice. But when tested weeks later, they couldn't remember what they had learned as well as normal mice, and they had trouble remembering contexts that should have provoked fear.
"These opposite effects on different types of learning are reminiscent of the mixed features of autistic patients, who may be disabled in some cognitive areas but show enhanced abilities in others," said Albert Y. Hung, a postdoctoral associate at the Picower Institute, staff neurologist at Massachusetts General Hospital and co-author of the study. "The superior learning ability of these mutant mice in a specific realm is reminiscent of human autistic savants."
Autism is one of a group of developmental disabilities known as autism spectrum disorders (ASDs), in which a person's ability to communicate and interact with others is impaired. The Centers for Disease Control and Prevention estimates that one in 150 American children has an ASD. Occasionally, an autistic person has an outstanding skill, such as an incredible rote memory or musical ability. Such individuals-like the character Dustin Hoffman played in the film Rain Man-may be referred to as autistic savants.
Hung said that while it seems counterintuitive that loss of an important synaptic scaffold protein would result in improved learning among the mice in this study, the absence of this protein may "trap" the mice's synapses in a more plastic state, which means the synapses are ready to respond to input but not maintain it in long-term memory.
Aberrant synapse development and faulty structure of dendritic spines-tiny protrusions on the surface of neurons that receive messages from other neurons-are often associated with neurodevelopmental disorders, including autism, in humans.
Hung; Morgan H. Sheng, MIT's Menicon Professor of Neuroscience; and colleagues investigated the role in brain development and cognitive function of a protein called Shank1. Shank1 is one member of a family of proteins that act as structural scaffolds linking together different components of the synapse. In humans, mutations in the closely related protein Shank3 have been linked to the autism spectrum of disorders characterized by impaired social interaction, absent or delayed language development and repetitive behaviors.
The mice in the study had smaller dendritic spines and weaker brain synapses. Their enhanced spatial learning is similar to that of mice engineered to have a mutation in another protein-neuroligin3-that binds directly to Shank1 and is also associated with autism. "We speculate that enhanced spatial learning might be a common feature of mouse models of autism, and that it might reflect a pathological elevation of brain plasticity in the human disease," Hung and Sheng wrote.
In addition to Hung and Sheng, a Howard Hughes Medical Institute (HHMI) investigator, MIT authors are Picower Institute research scientist Kensuke Futai; MIT biology graduate student Jubin Ryu; MIT biology undergraduate Mollie A. Woodworth, Picower Institute postdoctoral fellow Fleur L. Kidd; Picower Institute research assistant Clifford Sung; and Mark F. Bear, Picower Professor of Neuroscience, HHMI investigator and director of the Picower Institute. Additional authors are from the University of Milan, the University of North Carolina at Chapel Hill, and Fujita Health University in Japan.
This work was supported by the RIKEN-MIT Neuroscience Research Center, the National Institutes of Health and HHMI.
http://www.mit.edu
Visit our autism section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/96893.php>
APA
http://www.medicalnewstoday.com/releases/96893.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
SHANK3 Defect In Autism
posted by RAJ on 13 Feb 2008 at 7:17 pmSHANK3 defects have been found in ASD subjects but also in people with mental retardation without an ASD diagnosis. The failure of genetic research in autism is its inability to control for the confounding variable of mental retardation associated with autism type features.
http://www.ncbi.nlm.nih.gov/pubmed/16284256?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
In 1965 Leo Kanner, the clinician who first recognized autism as a distinct neuropsychiatric disorder voiced his objection to the 1960's 'epidemic' of autism when mentally retarded children with bizarre behaviors who shared one or more part features of the syndrome of autism were given the fashionable label of 'autism'.
The current vastly expanded definition and criteria used to confer a diagnosis are vague and subjective. This likely explains the second autism epidemic and also explains why such diverse children as Fragile X mentally retarded boys, brain damaged children, language delayed children and even Romanian orphans who were institutionalized as infants and suffered severe emotional deprivation, abuse and neglect can all meet diagnostic criteria for an ASD.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





